Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties
- PMID: 34282264
- PMCID: PMC8287276
- DOI: 10.1038/s41380-021-01222-x
Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties
Conflict of interest statement
DA has received travel grants from Jansen-Cilag and Servier and sponsorship from Lundbeck. The other authors report no conflict of interest.
Comment in
-
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms.Mol Psychiatry. 2021 Dec;26(12):7098-7099. doi: 10.1038/s41380-021-01254-3. Epub 2021 Aug 12. Mol Psychiatry. 2021. PMID: 34385600 Free PMC article. No abstract available.
Comment on
-
Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.Mol Psychiatry. 2021 Sep;26(9):5199-5212. doi: 10.1038/s41380-021-01021-4. Epub 2021 Feb 4. Mol Psychiatry. 2021. PMID: 33536545
References
-
- Hoertel N, Sánchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;4:1–14. - PubMed
-
- Hoertel N, Sánchez-Rico M, Gulbins E, Kornhuber J, Carpinteiro A, Lenze EJ, et al. Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID-19: an observational multicenter study. Clin Pharm Therap. 2021; 10.1002/cpt.2317 [e-pub ahead of print]. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical